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Adaptive designs for clinical trials have the potential to
improve the efficiency of clinical research by, for instance,
seamlessly combining different stages of a clinical develop-
ment programme. Adaptive seamless designs (ASD) com-
bining phases II and III with adaptations such as treatment
or subgroup selection are becoming increasingly widely
used. The work required to develop application specific
software for each new trial is a potential barrier to the
more extensive use of ASD, particularly as simulation stu-
dies are often required at the planning stage to explore a
range of options prior to deciding on an appropriate
design. A number of common analysis methods (e.g.
weighted inverse normal combination functions) and simu-
lation tools for assessing the performance of a number of
design options, are available in some widely used commer-
cial packages, but currently no free software exists for plan-
ning and simulation of ASD. Parsons et al. [1] developed R
package asd specifically for undertaking simulations to
investigate designs for treatment selection based on early
outcomes [2]. The freely available software simulates nor-
mal test statistics, rather than individual patient data, in the
setting of treatment selection, providing flexibility to deal
with combinations of scales (e.g. normal, binary) for both
early and final outcomes, for two stage designs. Two exam-
ples for normally distributed and binomially distributed
final outcomes are described with code demonstrating
implementation in the software and output to show how
this methodology can be used explore a range of options
prior to deciding on an appropriate trial design. The soft-
ware is flexible and fast, allowing many design options to
be explored, and is currently in the process of being
extended in a new version that will also include simulations
for subpopulation selection. The software is available from
the Comprehensive R Archive Network [http://cran.r-pro-
ject.org/] and more details can be found at the Package
Website [http://cran.r-project.org/web/packages/asd/].
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